Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.
M Wang(National Institutes of Health), Nicholas P. Restifo(Lyell Immunopharma (United States)), Dennis Panicali(Fox Chase Cancer Center), Steven A. Rosenberg(National Cancer Institute), Linda Gritz, P W Chen(National Institutes of Health), Vincenzo Bronte(University of Verona)
Cited by 232
Related Papers
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
|Cell|1991|1.6k
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
|Journal of Clinical Oncology|2008|1.3k
IL-2: The First Effective Immunotherapy for Human Cancer
|The Journal of Immunology|2014|1.3k
Altered macrophage differentiation and immune dysfunction in tumor development
|Journal of Clinical Investigation|2007|1.2k